MAMusa Aydınlı

Musa Aydınlı

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Musa Aydınlı has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Peritonitis due to brucellosis in a patient newly diagnosed with liver cirrhosis complicated by ascites: A case report and literature review

    by Remzi Ekici, Mine Filiz, Sefa Onus, Ali Gokhan Akcay, Tolga Bakir, Galip Buyukturan, Emine Gul Aydin, Mustafa Ekici, Musa Aydinli, Cemal Nuri Ercin

    Brucellosis is a common zoonotic disease with a wide variety of clinical manifestations. Spontaneous bacterial peritonitis (SBP) is a rare form among them. Here, we present the case of a 63-year-old woman with newly diagnosed liver cirrhosis complicated with ascites and diagnosed as spontaneous bacterial peritonitis with Brucella spp. growth in culture, and the literature is reviewed.

  • Solitary Rectal Ulcer Diagnosed in a Malignancy-Mimicking Polypoid Rectal Lesion: A Case Report

    by Remzi Ekici, Musa Aydınlı

    Solitary rectal ulcer syndrome (SRUS) is a chronic anorectal disorder of unknown etiology, most commonly observed in young adults. The diagnosis is established through a combination of clinical, endoscopic, and histopathological findings. Its polypoid appearance, which may mimic malignancy, often leads to misdiagnosis. Herein, we present the case of a 64-year-old woman with a history of constipation and digital evacuation, who was found to have a polypoid rectal lesion resembling malignancy, which was subsequently diagnosed as SRUS.

  • Open Access

    Evaluation of Her2 Positivity in Gastric Cancer Using Two Different Methods: A Prospective Study

    by Abdi İbRahim Sönmez, Alper Sevinc, İbrahim Sarı, İrFan Koruk, Musa Aydınlı, Serdar Öztuzcu, Beyhan Cengiz

    BACKGROUND: Stomach cancer is one of the most common gastrointestinal tract tumors. Its incidence varies according to ethnic group, geographical conditions, dietary habits, economic status, lifestyle and Helicobacter pylori prevalence. Genetic factors play a major role in the pathogenesis of gastric cancer, and the human epidermal growth factor receptor 2 Her2/neu (c-erb B2) gene is one of these factors. METHOD: The objective of this study is to compare any correlation between the amplification level of Her2/neu gene in gastric cancer by real-time polymerase chain reaction (RT-PCR) with Her2 protein overexpression obtained from the same tissue and studied with immunohistochemisry (IHC), and in the event of positivity, to determine its relationshipwith other known prognostic factors such as age, gender, stage, tumor localization and histological type. RESULTS: IHC results indicated Her2 overexpression in 5 (10%) patients and RT-PCRindicated amplification also in 5 (10%) patients. There was no significant correlation between the results determined by the two methods (p> 0.05). Additionally, no statistically significant difference was detected between prognostic factors and gene expressions in tumor tissues (p> 0.05). CONCLUSION: Her2 gene amplification and protein overexpression can potentially contribute to tumor development. Further studies are needed to evaluate false negativity, investigate patient survival in terms of its contribution to prognosis, and corroborate our hypothesis.